Publications

Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2002. PMID: 11996478


Thomas Martin, MD

Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A. Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation. EMBO reports. 2002. PMID: 11850397


Alan Ashworth, PhD

Basso AD, Solit DB, Munster PN, Rosen N. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene. 2002. PMID: 11850835


Pamela Munster, MD

Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone marrow transplantation. 2002. PMID: 11896426


Jeffrey Wolf, MD

Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone marrow transplantation. 2002. PMID: 11896426


Lloyd Damon, MD

Harmon EB, Ko AH, Kim SK. Hedgehog signaling in gastrointestinal development and disease. Volume 2 of Issue 1 Current molecular medicine. 2002. PMID: 11898849


Andrew Ko, MD

Oh WK, Small EJ. PC-SPES and prostate cancer. The Urologic clinics of North America. 2002. PMID: 12109356


Eric Small, MD

Lee SR, Ramos SM, Ko A, Masiello D, Swanson KD, Lu ML, Balk SP. AR and ER interaction with a p21-activated kinase (PAK6). Volume 16 of Issue 1 Molecular endocrinology (Baltimore, Md.). 2002. PMID: 11773441


Andrew Ko, MD

Komanduri KV. Thymic function and allogeneic T-cell responses in stem-cell transplantation. Cytotherapy. 2002. PMID: 12396833


Krishna Komanduri, MD

Gordan JD, Vonderheide RH. Universal tumor antigens as targets for immunotherapy. Cytotherapy. 2002. PMID: 12396831


John Gordan, MD, PhD

Augustine SC, Norenberg JP, Colcher DM, Vose JM, Gobar LS, Dukat VJ, Hohenstein MA, Rutar FJ, Jacobson DA, Tempero MA. Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice. Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 2002. PMID: 11833524


Margaret Tempero, MD

Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer research. 2001. PMID: 11731433


Pamela Munster, MD

Gordon KB, Rugo HS, Duncan JL, Irvine AR, Howes EL, O'Brien JM, Carter SR. Ocular manifestations of leukemia: leukemic infiltration versus infectious process. Ophthalmology. 2001. PMID: 11733273


Hope Rugo, MD

Elfman F, Bok R, Conn M, Shuman M, Cunha G. Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate. Differentiation; research in biological diversity. 2001. PMID: 11798065


Marc Shuman, MD

Patterson S, Ko A, O'Connell TX. Radiation after mastectomy in high-risk patients: is it necessary? Volume 67 of Issue 12 The American surgeon. 2001. PMID: 11768832


Andrew Ko, MD

Fornier MN, Seidman AD, Theodoulou M, Moynahan ME, Currie V, Moasser M, Sklarin N, Gilewski T, D'Andrea G, Salvaggio R, Panageas KS, Norton L, Hudis C. Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001. PMID: 11751485


Mark Moasser, MD

Sayre PH, Finer-Moore JS, Fritz TA, Biermann D, Gates SB, MacKellar WC, Patel VF, Stroud RM. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases. Volume 313 of Issue 4 Journal of molecular biology. 2001. PMID: 11697906


Peter Sayre, MD, PhD

Munster PN, Horton J. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001. Cancer control : journal of the Moffitt Cancer Center. 2001. PMID: 11807416


Pamela Munster, MD

Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proceedings of the National Academy of Sciences of the United States of America. 2001. PMID: 11687611


Katherine Van Loon , MD, MPH

Moasser MM, Basso A, Averbuch SD, Rosen N. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer research. 2001. PMID: 11585753


Mark Moasser, MD